Köhrle Josef
Institut für Experimentelle Endokrinologie und Endokrinologisches Forschungszentrum der Charité EnForCé, Charité Universitätsmedizin Berlin, CCM Charitéplatz 1, Berlin, Germany.
Best Pract Res Clin Endocrinol Metab. 2007 Jun;21(2):173-91. doi: 10.1016/j.beem.2007.04.001.
Thyroid hormone metabolism by the three deiodinase selenoproteins -- DIO1, DIO2, and DIO3 -- regulates the local availability of various iodothyronine metabolites and thus mediates their effects on gene expression, thermoregulation, energy metabolism, and many key reactions during the development and maintenance of an adult organism. Circulating serum levels of thyroid hormone and thyroid-stimulating hormone, used as a combined indicator of thyroid hormone status, reflect a composite picture of: thyroid secretion; tissue-specific production of T(3) by DIO1 and DIO2 activity, which both contribute to circulating levels of T(3); and degradation of the prohormone T4, of the thyromimetically active T(3), of the inactive rT(3), of other iodothyronines metabolites with a lower iodine content and of thyroid hormone conjugates. Degradation reactions are catalyzed by either DIO1 or DIO3. Aberrant expression of individual deiodinases in disease, single nucleotide polymorphisms in their genes, and novel regulators of DIO gene expression (such as bile acids) provide a more complex picture of the fine tuning and the adaptation of systemic and local bioavailability of thyroid hormones.
三种脱碘酶硒蛋白(DIO1、DIO2和DIO3)参与甲状腺激素代谢,调节各种碘甲状腺原氨酸代谢物的局部可用性,从而介导它们对基因表达、体温调节、能量代谢以及成年生物体发育和维持过程中许多关键反应的影响。作为甲状腺激素状态综合指标的循环血清甲状腺激素和促甲状腺激素水平反映了以下综合情况:甲状腺分泌;DIO1和DIO2活性导致的T(3)组织特异性产生,这两者都对循环T(3)水平有贡献;以及前体激素T4、甲状腺模拟活性T(3)、无活性rT(3)、其他低碘含量碘甲状腺原氨酸代谢物和甲状腺激素共轭物的降解。降解反应由DIO1或DIO3催化。疾病中单个脱碘酶的异常表达、其基因中的单核苷酸多态性以及DIO基因表达的新型调节因子(如胆汁酸),为甲状腺激素全身和局部生物利用度的精细调节和适应性提供了更复杂的情况。